In the era of rapid mRNA-based vaccines: why is there no effective hepatitis C virus vaccine yet?
Hepatitis C virus (HCV) is responsible for no less than 71 million people chronically infected and is one of the most frequent indications for liver transplantation worldwide. Despite direct-acting antiviral therapies fuel optimism in controlling HCV infections, there are several obstacles regarding...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , |
| Format: | article |
| Language: | English |
| Published: |
2021
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/20.500.12008/41395 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: In the era of rapid mRNA-based vaccines: why is there no effective hepatitis C virus vaccine yet?
- Midgut barriers prevent the replication and dissemination of the yellow fever vaccine in Aedes aegypti
- About tetanus vaccination
- Chikungunya virus vaccine candidates with decreased mutational robustness are attenuated in vivo and have compromised transmissibility
- About tetanus vaccination
- Vaccination with Cathepsin L Proteinases and with Leucine Aminopeptidase Induces High Levels of Protection against Fascioliasis in Sheep
- Leaf Saponins of Quillaja brasiliensis as Powerful Vaccine Adjuvants